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Inflammation maywellbeonlyonefacetofa
time-anddose-dependentcontinuum oftoxicological
processesforaspecificagent.
Editorial
Inflammation, Tumor Necrosis Factor,
and Toxicology
At the recent Society ofToxicology annual meeting in March, Debra
Laskin of Rutgers University presented the Burroughs Wellcome
Toxicology Scholars Award Lecture titled "Mechanisms of Chemical
Toxicity: The Dark Side ofthe Immune System," which described the
role ofinflammatory processes in exacerbating hepatotoxicity after use
ofthe common pain reliever acetaminophen.
The role ofinflammation in toxicological responses is viewed with
considerable interest by many immunologists and toxicologists as more
diseases-ranging from arthritis and Alzheimer's to idiopathic pul-
monary fibrosis and chronic hepatitis-manifest an inflammatory com-
ponent that increases, albeit to avaryingdegrees, disease severity (1).
The underlying hypothesis that links these pathologies can be sum-
marized as follows: Initial injury, whether initiated by an infectious,
chemical, or environmental agent, produces focal tissue necrosis in a
target organ through any one of several toxic mechanisms (e.g., lipid
peroxidation, mitochondrial damage). As a result of this damage, tis-
sue-fixed macrophages and circulating monocytes migrate to the dam-
aged site, become activated, and secrete products that cause additional
cell damage or induction of inflammatory products. Some of these
products are short-lived, such as reactive oxygen species and the nitro-
gen-centered radical nitric oxide (NO.). Other products, such as
arachidonic acid and proinflammatory cytokines, regulate the produc-
tion ofadditional inflammatory mediators and thus amplify as well as
propagate these responses. The overall effect is a chronic inflammatory
response resulting in tissuedamage that can lead to fibrotic changes.
Although many factors contribute to the inflammatory response,
arguably tumor necrosis factor (TNF)a plays the major role in regulat-
ing this process. The cellular effects of TNFa include physiologic,
cytotoxic, and inflammatory processes (2,3). In homeostasis, TNFa
influences mitogenesis, differentiation, and immunoregulation while
causing apoptotic cell death in neoplastic cell lines. Cytotoxicity by
TNFa occurs independently of de novo transcription and translation
and involves mitochondrial production of oxygen radicals generated
primarily at the ubisemiquinone site. This requires ceramide, a sphin-
golipid generated in cells following stimulation with TNFa, which
generates H202 from the mitochondrial electron transport chain. In
contrast to cytotoxicity, TNFa regulates inflammatory processes
through the induction of genes that code for mediators [e.g., inter-
leukin (IL)-1, IL-6, IL-8, macrophage inflammatory protein (MIP)-2,
granulocyte-macrophage colony-stimulating factor, intracellular adhe-
sion molecule-i, endothelial leukocyte adhesion molecule-i]. In con-
cert, these mediators locally enhance vascular permeability, stimulate
the expression ofadhesion molecules on endothelial cells, and serve as
leukocyte chemoattractants (chemokines).
Once activated neutrophils and circulating monocytes infiltrate a
site, they cause additional damage through degranulation and release of
neutral proteinase or the generation of superoxide anions (O2-) via
NADPH-oxidase during the respiratory burst. O2-' which itselfmedi-
ates tissue damage, can be further reduced to other toxic reactive oxy-
gen intermediates, including H202 and hydroxyl radical (OH.) (4).
The ultimate toxicity of02- may depend on its ability to bring about
the reduction of Fe+3 to Fe+2, providing for the generation of OH
from H202, and to interact with W
NO. to generate ONOO- and subse-
quently OH. Central to the abilityof
TNFa to induce inflammatory gene
expression is its ability to activate the
nuclear transcription factor NF-
iKB(5). NF-iB is a dimer of the Rel
family of proteins that becomes acti-
vated following dissociation of an
inhibitor protein belonging to the
lKB family. Cell signaling events that occur following binding of
TNFa to cell surface receptors and prior to NF-iKB activation are
under intense investigation but can involve protein kinases, proteases,
protein phosphatases, sphingomyelinases, and phospholipases. Two
distinct families of proteins, the TNF receptor-associated factors and
the death domain homologs, help coordinate cell- and tissue-specific
responses in this complexsignalingpathway (6).
Several lines ofevidence suggest that TNFa mediates organ-specif-
ic toxic responses: 1) elevated levels ofTNFa can be found in target
organs following exposure to certain occupational and environmental
agents; 2) administration of TNFa in experimental animals mimics
many of the pathophysiological responses associated with the toxic
response; 3) inhibition ofTNFa, either by administering neutralizing
agents or by using TNF transgenic mice (knockouts), prevents manyof
the pathophysiological responses from occurring; and 4) organs in
which these types ofresponses occur contain tissue-fixed macrophages
or other cells that produce high levels ofTNFa.
Chronic inflammatory lung diseases, such as idiopathic pulmonary
fibrosis, chronic bronchitis, adult respiratory disease syndrome, cystic
fibrosis, and some forms of asthma, are associated with elevated TNF
responses and neutrophil accumulation in the lung. Increased levels of
TNFa have also been found in bronchoalveolar lavage fluid, generated
primarilyfrom alveolar macrophages following inhalation ofenvironmen-
tal agents associated with pulmonary inflammation (ozone, diesel parti-
cles), fibrosis (silica, asbestos), orgranulomatous responses (beryllium).
TNFa levels are reduced in the lungs of smokers compared to
nonsmokers, which may account for the increased susceptibility of
smokers to infections and decreased incidences of some autoimmune
and inflammatory diseases. Direct evidence for a role ofTNFa in these
environmental lung diseases comes from observations that mice pre-
treated with soluble TNF receptors or neutralizing antibodies to
TNFa are resistant to silica or bleomycin-induced pulmonary fibrosis
(4-). Recently our laboratory, in collaboration with Meryl Karol at the
University of Pittsburgh, observed that transgenic mice lacking TNF
receptors failed to develop any manifestations ofTDI asthma includ-
ing IgE antibodies and inflammation.
A role for TNFa in chemical-induced hepatotoxicity was suggested
by studies that demonstrate its involvement in hepatic injury during
sepsis and ischaemia reperfusion. TNFa administered to rodents initi-
ates acute phase responses, inflammatory cell infiltration, hyperlipi-
demia, fibrogenesis, and cholestasis. Subsequent studies indicated that
many hepatotoxic chemicals including CC14, acetaminophen, CdCI2,
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alcohol, aflatoxin B1, and 1,2-dichlorobenzene can be attenuated by
agents which deplete neutrophils or block Kupffer cell function, such
as gadolinium chloride. Kupffer cells are the resident liver macrophages
and the major source ofinducible TNFa in the liver. Recently, elevat-
ed TNFa levels have been observed in mice exposed to hepatotoxic
concentrations of CC14, CdCl2, acetaminophen, alcohol, and dimeth-
lylnitrosamine. Furthermore, pretreatment ofanimals with neutralizing
antibodies to TNFa prior to chemical exposure abrogates, albeit to
varying degrees, hepatotoxicity associated with a number of these
chemical exposures (8). Under different conditions, TNFa can pro-
mote liver repair following chemical damage by serving as a hepatocyte
mitogen (9). In this respect, TNFa is required for liver regeneration
following partial hepatectomy.
Analogous to its role in maturation ofhematopoietic and immuno-
logic cells, TNFa participates in cell apoptosis, differentiation, and
proliferation in the central nervous system. Overexpression ofTNFa
in microglia is associated with autoimmune diseases such as multiple
sclerosis and experimental autoimmune encephalomyelitis and has
been postulated to be involved in neurodegenerative diseases including
Alzheimer's disease, Parkinson's disease, and AIDS dementia (10).
Studies on its influence on environmental- or occupational-related
neurotoxicity is limited to observations ofa rapid and early increase of
TNFa message at specific sites in the brain following mechanical dam-
age or exposure to neurotoxic doses oftrimethyltin in rodents (11).
In the skin, TNFa gene expression occurs in the epidermis within
minutes after either physical disruption (UV irradiation, burns,
wounding) or application ofchemical sensitizers or irritants. The func-
tion ofTNFa in allergic and irritant contact dermatitis is similar to its
role in other organ systems and involves regulation of immune and
inflammatory processes. An additional role for TNFa in the skin is to
provide a signal for Langerhan's cell migration from the epidermis to
the draining lymph node (12), an event required for induction of an
immune response. Similar to other organ systems, diminished respons-
es to contact allergens and irritants are observed in the skin of mice
rendered deficient in TNFa responses either through genetic alter-
ations or administration ofneutralizing agents.
In summary, only recently have toxicologists come to appreciate the
role inflammation plays in classical toxicological processes. This rela-
tionship can be extremely complex, as inflammation may well be only
one facet of a time- and dose-dependent continuum of toxicological
processes for a specific agent. On the other hand, these mediators are
also involved in normal physiological and repair processes. Rendering a
host incapable ofmounting an inflammatory response would be detri-
mental. Nonetheless, it may not be long before we administer (as has
been indicated for so many other diseases) an aspirin a day as prophy-
laxis for environmental/occupational maladies.
Michael I. Luster
Toxicology and Molecular Biology Branch
National Institute for Occupational Safetyand Health
Morgantown, West Virginia
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